TFS Capital’s Histogen Inc. Common Stock HSTO Stock Holding History

TFS Capital’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-116	Closed	-$134K	–	437
2017 Q2	$134K	Buy	+116	New	+$141K	0.05%	517

Other funds holding HSTO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TFS Capital's HSTO Position: Q3 2017 in Review

TFS Capital sold out of Histogen Inc. Common Stock (HSTO) in Q3 2017, closing a stake of 116 shares — an estimated $134K sold.

TFS Capital first reported a position in HSTO in Q2 2017 and held it in 1 quarter. The position peaked at $134K in Q2 2017. 78 funds tracked by Wall St. Rank hold HSTO as of Q3 2017.

TFS Capital reported no remaining Histogen Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
TFS Capital sold 116 Histogen Inc. Common Stock shares in Q3 2017, an estimated $134K.
TFS Capital first reported a position in Histogen Inc. Common Stock in Q2 2017 and held it in 1 quarter.
TFS Capital's Histogen Inc. Common Stock position peaked at $134K in Q2 2017.
78 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.